Lipids and atherosclerosis

Biochemistry of Lipids, Lipoproteins and Membranes

Volumn , Issue , 2008, Pages 579-605

  Tabas, Ira ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952219194     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044453219-0.50023-4     Document Type: Chapter

References (35)

1. Stary H.C. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler. Thromb. Vasc. Biol 2000, 20:1177-1178.
2. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell 2001, 104:503-516.
3. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 1995, 57:791-804.
4. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1995, 15:551-561.
5. Williams K.J., Tabas I. The response-to-retention hypothesis of atherogenesis, reinforced. Curr. Opin. Lipidol. 1998, 9:471-474.
6. Small D.M. Progression and regression of atherosclerotic lesions. Arteriosclerosis 1988, 8:103-129.
7. Aikawa M., Libby R. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc. Pathol. 2004, 13:125-138.
8. Tabas I. Nonoxidative modifications of lipoproteins in atherogenesis. Annu. Rev. Nutr. 1999, 19:123-139.
9. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 2002, 110:905-911.
10. Kruth H.S., Jones N.L., Huang W., Zhao B., Ishii I., Chang J., Combs C.A., Malide D., Zhang W.Y. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 2005, 280:2352-2360.
11. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., McKee M., Freeman M.W. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J. Clin. Invest. 2005, 115:2192-2201.
12. Oorni K., Pentikainen M.O., Ala-Korpela M., Kovanen P.T. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J. Lipid. Res. 2000, 41:1703-1714.
13. Tabas I. Secretory sphingomyelinase. Chem. Phys. Lipids 1999, 102:123-130.
14. Maxfield F.R., Tabas I. Role of cholesterol and lipid organization in disease. Nature 2005, 438:612-621.
15. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983, 52:223-261.
16. Chang T.Y., Chang C.C.Y., Cheng D. Acyl-coenzyme Axholesterol acyltransferase. Annu. Rev. Biochem. 1997, 66:613-638.
17. Katz S.S., Shipley G.G., Small D.M. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J. Clin. Invest. 1976, 58:200-211.
18. Llodra J., Angeli V., Liu J., Trogan E., Fisher E.A., Randolph G.J. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11779-11784.
19. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
20. Tontonoz P., Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 2003, 17:985-993.
21. Bruemmer D., Law R.E. Liver x receptors: potential novel targets in cardiovascular diseases. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5:533-540.
22. Durrington P.N. Triglycerides are more important in atherosclerosis than epidemiology has suggested. Atherosclerosis 1998, 141(Suppl. 1):S57-S62.
23. FitzGerald G.A., Austin S., Egan K., Cheng Y., Pratico D. Cyclo-oxygenase products and atherothrombosis. Ann. Med. 2000, 32(Suppl. 1):21-26.
24. Pratico D., Rokach J., Lawson J., FitzGerald G.A. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem. Phys. Lipids 2004, 128:165-171.
25. Khan Z., Tripathi C.D. Leukotrienes and atherosclerosis. Indian Heart J. 2005, 57:175-180.
26. Hirafuji M., Machida T., Hamaue N., Minami M. Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J. Pharmacol. Sci. 2003, 92:308-316.
27. Berliner J.A., Watson A.D. A role for oxidized phospholipids in atherosclerosis. N. Engl. J. Med. 2005, 353:9-11.
28. Navab M., Berliner J.A., Subbanagounder G., Hama S., Lusis A.J., Castellani L.W., Reddy S., Shih D., Shi W., Watson A.D., et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 2001, 21:481-488.
29. Chatterjee S., Kolmakova A., Miller M. The role of the phospholipid sphingomyelin in heart disease. Curr. Opin. Investig. Drugs 2006, 7:219-228.
30. Tamama K., Okajima F. Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology. Curr. Opin. Lipidol. 2002, 13:489-495.
31. Nievelstein P.F., Fogelman A.M., Mottino G., Frank J.S. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler. Thromb 1991, 11:1795-1805.
32. Tabas I., Li Y., Brocia R.W., Xu S.W., Swenson T.L., Williams K.J. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein (a) retention and macrophage foam cell formation. J Biol. Chem. 1993, 268:20419-20432.
33. Tabas I., Marathe S., Keesler G.A., Beatini N., Shiratori Y. Evidence that the initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterol-induced cellular necrosis. Proposed role of an eventual failure of this response in foam cell necrosis in advanced atherosclerosis. J Biol. Chem. 1996, 271:22773-22781.
34. Shio H., Haley N.J., Fowler S. Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. III. Intracellular localization of cholesterol and cholesteryl ester. Lab. Invest. 1979, 41:160-167.
35. Zhou J., Lhoták S., Hilditch B.A., Austin R.C. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 2005, 111:1814-1821.